Evidence map›Paper›PMID 39960224›Full record

ArticleMolecular pharmaceutics2025

Maximilian Alexander Zierke, Christine Rangger, Kimia Samadikhah, Andreas Martin Schmid, Roland Haubner

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Comparison of twoEJNMMI radiopharmacy and chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maximilian Alexander ZierkeDepartment of Nuclear Medicine, Medical University Innsbruck, Anichstr. 35, Innsbruck 6020, Austria.ORCID 0000-0001-5667-9831
Christine RanggerDepartment of Nuclear Medicine, Medical University Innsbruck, Anichstr. 35, Innsbruck 6020, Austria.
Kimia SamadikhahWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Röntgenweg 13, Tübingen 73076, Germany.
Andreas Martin SchmidWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Röntgenweg 13, Tübingen 73076, Germany.
Roland HaubnerDepartment of Nuclear Medicine, Medical University Innsbruck, Anichstr. 35, Innsbruck 6020, Austria.ORCID 0000-0002-4665-7433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

Gallium RadioisotopesGlycopeptidesLiverRadiopharmaceuticalsAnimalsAsialoglycoprotein ReceptorClick ChemistryHumansMiceTissue DistributionTomography, Emission-Computed, Single-PhotonAsialoglycoprotein ReceptorGallium-68Gallium RadioisotopesGlycopeptidesRadiopharmaceuticalsAsialoglycoprotein receptorfunctional liver imaginggallium-68glycopeptidespositron emission tomography

Identifiers

PMID39960224
PMCPMC11881035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.